Risiko
Bærekraft
🌳
🌳
🌳
(1 av 3)
Pris
0,25%
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
10 største eierandeler
Eli Lilly and Co
11,9%
UnitedHealth Group Inc
9,3%
Johnson & Johnson
6,8%
AbbVie Inc
6,0%
Merck & Co Inc
4,7%
Thermo Fisher Scientific Inc
4,3%
Abbott Laboratories
4,1%
Intuitive Surgical Inc
3,8%
Amgen Inc
2,9%
Boston Scientific Corp
2,8%
Helse
100,0%
Nord-Amerika
100,0%
Totalpris (det du betaler årlig):
0,25%
Prisdetaljer
Pris for fondet:
0,15%
Plattformavgift:
0,10%
Vis priser med rabatt for Akademikerne Pluss eller Tekna
Avkastning pr. 04.02
Siste måned:
4,8%
Siste 6 måneder:
2,0%
Hittil i år:
6,2%
Siste år:
10,7%
Siste 3 år (per år):
13,9%
Siste 5 år (per år):
13,3%
Morningstar-rating:
5
ISIN:
IE00B43HR379
Forvaltningskapital:
27 343 557 636 kr
Kategori:
Bransjefond, Helsevern
NAV/Kurs (04.02.2025):
130 kr
Obligasjoner:
0,0%
Kontanter:
0,0%
Aksjer:
100,0%
Annet:
0,0%
Startdato:
20.11.2015